openPR Logo
Press release

Investigation announced for Investors who lost money with shares of R1 RCM Inc. (NASDAQ: RCM)

10-24-2023 07:55 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in R1 RCM Inc. (NASDAQ: RCM) shares over potential securities laws violations by R1 RCM Inc.

An investigation for investors in R1 RCM Inc. (NASDAQ: RCM) shares over potential securities laws violations by R1 RCM Inc.

An investigation was announced over potential securities laws violations by R1 RCM Inc. in connection with certain financial statements.

Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of R1 RCM Inc. (NASDAQ: RCM) concerning whether a series of statements by R1 RCM Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Murray, UT based R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. R1 RCM Inc. reported that its annual Total Revenue rose from over $1.47 billion in 2021 to over $1.8 billion in 2022, and that its Net Income of $97.2 million in 2021 declined to a Net Loss of $5.76 million in 2022.

On October 16, 2023, Jehoshaphat Research issued a report alleging accounting issues, conflicts of interest, and governance concerns at R1 RCM, Inc. The Jehoshaphat Report claims that "RCM's revenues and profits are grossly overstated by a variety of desperate accounting measures, and that horrific corporate governance has allowed this to happen."

Shares of R1 RCM Inc. (NASDAQ: RCM) declined from $18.69 per share on July 03, 2023, to $11.02 per share on October 18, 2023.

Those who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with shares of R1 RCM Inc. (NASDAQ: RCM) here

News-ID: 3261032 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for RCM

RCM Matter, a TechMatter Company, Introduces Next-Gen Medical Billing & RCM Soft …
GLENDALE, CA, UNITED STATES, August 27, 2025 -- RCM Matter, a subsidiary of TechMatter, announced the launch of its flagship product, a next-generation Medical Billing and Revenue Cycle Management (RCM) software solution that's built for modern-day healthcare practices. The platform empowers providers with automation, compliance, and transparency, helping them reduce administrative stress and strengthen financial performance. Built from the ground up with healthcare teams in mind, the RCM software offers
Healthcare RCM Outsourcing Market Report 2024 - RCM Outsourcing Market Trends, S …
"The Business Research Company recently released a comprehensive report on the Global Healthcare RCM Outsourcing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Murray,
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its
Investigation announced for Investors in shares of R1 RCM Inc. (NASDAQ: RCM)
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Chicago,
Healthcare Rcm Outsourcing Market DRIVES FUTURE CHANGE | Availity, The SSI Group …
Global Healthcare Rcm Outsourcing Market Growth (Status And Outlook) 2024, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare Rcm Outsourcin market,